Therapie der pulmonal arteriellen Hypertonie (PAH)

Abstract

The 2009 European Guidelines on Diagnosis and Treatment of Pulmonary Hypertension have been adopted for Germany. The guidelines contain detailed recommendations for the treatment of pulmonary arterial hypertension (PAH). However, the practical implementation of the European Guidelines in Germany requires the consideration of several country-specific issues and already existing novel data. This requires a detailed commentary to the guidelines, and in some aspects an update already appears necessary. In June 2010, a Consensus Conference organized by the PH working groups of the German Society of Cardiology (DGK), the German Society of Respiratory Medicine (DGP) and the German Society of Pediatric Cardiology (DGPK) was held in Cologne, Germany. This conference aimed to solve practical and controversial issues surrounding the implementation of the European Guidelines in Germany. To this end, a number of working groups was initiated, one of which was specifically dedicated to the treatment of PAH. This commentary summarizes the results and recommendations of the working group on treatment of PAH.

Allgemeine Therapie der pulmonal arteriellen Hypertonie

“…Bei rechtsatrialem Vorhofflattern bietet eine kavotrikuspidale Isthmus-Ablation gute Erfolgsaussichten [39]. Beta-Blocker und Kalzium-Antagonisten sind risikoreich wegen ihrer negativ inotropen Eigenschaften, können aber im Einzelfall indiziert sein [40]. Digitalis kann allenfalls zur Frequenzkontrolle empfohlen werden, wenn eine Rhythmuskontrolle nicht möglich ist.…”